Skip to main content
. 2020 Aug 14;20:599. doi: 10.1186/s12879-020-05291-1

Table 3.

Univariate analysis of mortality risk factors in patients in the intensive care unit with fungal bloodstream infections

Variable Survival (n = 52) Death (n = 29) χ2/F P
Sex, male/female (n) 32/20 18/11 0.002 0.962
Age (years; mean ± s.d.) 56.9 ± 10.4 65.7 ± 11.8 10.619 0.001
Disease factors
 Diabetes (n) 10 12 4.616 0.032
 Malignant tumor (n) 3 4 1.518 0.218
 Cardiovascular disease (n) 8 16 14.135 0.000
 Chronic obstructive pulmonary disease (COPD) (n) 5 4 0.329 0.566
 Digestive tract disease (n) 5 4 0.329 0.566
 Urinary system disease (n) 8 6 0.366 0.545
 Hypertension (n) 13 13 3.358 0.067
 Serum albumin (g/L) 39.5 ± 8.6 33.1 ± 10.7 7.91 0.005
 Serum urea nitrogen (μmol/L) 19.1 ± 27 30.7 ± 53.2 1.693 0.193
 γ-gamma glutamyl peptidase (U/L) 36.2 ± 24.7 63.8 ± 67.6 6.629 0.010
 Acute Physiology and Chronic Health Evaluation (APACHE) II score 16.32 ± 1.74 19.97 ± 2.90 31.565 0.000
 Merger of three or more underlying diseases (n) 6 12 7.82 0.005
Invasive operative factors
 Tracheal intubation (n) 16 13 1.601 0.206
 Multi cavity catheter (n) 11 11 2.649 0.104
 Central venous catheterization (n) 23 16 0.893 0.345
 Catheter retention time (d) 12.0 ± 4.0 14.6 ± 5.8 5.070 0.024
Therapeutic factors
 Hospitalization time in ICU (d) 9.7 ± 3.8 12.1 ± 6.7 4.401 0.036
 Gastrointestinal nutrition (n) 21 14 0.472 0.492
 Emergency tube (n) 18 14 1.454 0.228
 Blood transfusion (n) 17 12 0.611 0.434
 Central venous catheter(n) 33 20 0.249 0.804
 Patients in shock receiving cathecholamines etc. (n) 20 15 1.334 0.350
 Combined use of antibiotics (n) 25 18 1.464 0.254

χ2/F, chi-squared value; P probability